Hematological, Immunological, and Inflammation markers in Patients of COVID-19.

Cell Mol Biol (Noisy-le-grand)

Department of Biology, College of Science, Salahaddin University, Erbil, Iraq.

Published: February 2023

The present study was done to evaluate hematological, immunological, and inflammation markers in male and female patients infected with COVID-19, ranging from moderate to severe cases in Erbil city of Iraq. The study included 200 samples (60 male, and 60 female patients infected with COVID-19). While 40 healthy males and 40 healthy females were used as a control group. The results found significant differences in total white blood cells (WBC), lymphocytes, immunoglobin G (IgG), immunoglobin M (IgM), C-reactive protein (CRP), Ferritin, and erythrocyte sedimentation rate (ESR) between healthy control and patients infected with COVID-19 in males and females. Patients with COVID -19 showed a significantly p≤ 0.001 higher value of total WBC, IgG, IgM, CRP, Ferritin, and ESR when compared with the control group in both males and females. The percentage of lymphocytes in male and female patients is significantly p≤ 0.001  lower than that of the healthy control group. No significant differences in red blood cells (RBC), hemoglobin (Hb), hematocrit (HCT), and thrombocytes were observed between the control and patient groups in both males and females.

Download full-text PDF

Source
http://dx.doi.org/10.14715/cmb/2023.69.2.13DOI Listing

Publication Analysis

Top Keywords

male female
12
female patients
12
patients infected
12
infected covid-19
12
control group
12
males females
12
hematological immunological
8
immunological inflammation
8
inflammation markers
8
group differences
8

Similar Publications

Purpose: Our study evaluated skeletal muscle mass, function and quality among mild autonomous cortisol secretion (MACS) patients and non-functioning adrenal incidentaloma (NFAI) patients in comparison with the control group without adrenal mass.

Methods: 63 NFAI (49 female, 14 male) and 31 MACS (24 female, 7 male) patients were included in the study. As the control group, 44 patients (31 women, 13 men) who were known to have no radiological adrenal pathology on computed tomography or magnetic resonance imaging performed for other reasons were selected.

View Article and Find Full Text PDF

18F-Sodium Fluoride PET/CT as a Tool to Assess Enthesopathies in X-Linked Hypophosphatemia.

Calcif Tissue Int

January 2025

Endocrinology Department, School of Medicine, Pontificia Universidad Católica de Chile, Av. Diagonal Paraguay 262, Cuarto Piso, Santiago, Chile.

X-linked hypophosphatemia (XLH) is a rare metabolic disorder characterized by elevated FGF23 and chronic hypophosphatemia, leading to impaired skeletal mineralization and enthesopathies that are associated with pain, stiffness, and diminished quality of life. The natural history of enthesopathies in XLH remains poorly defined, partly due to absence of a sensitive quantitative tool for assessment and monitoring. This study investigates the utility of 18F-NaF PET/CT scans in characterizing enthesopathies in XLH subjects.

View Article and Find Full Text PDF

Objective: To review and compare robot-assisted ipsilateral ureteroureterostomy (RALUU) and laparoscopic ipsilateral uretero-ureterostomy (LUU) in terms of efficacy and outcomes.

Methods: Clinical data of 65 children with complete renal ureteral duplication deformity admitted to the First Affiliated Hospital of Zhengzhou University from January 2015 to December 2022 were collected. Among these, 42 patients underwent laparoscopic ureteroureterostomy (LUU), designated as the LUU group, while 23 patients received robot-assisted laparoscopic ureteroureterostomy (RALUU), designated as the RALUU group.

View Article and Find Full Text PDF

How low should we go? Outcomes of ECMO in neonates with low gestational age or birth weight.

Pediatr Surg Int

January 2025

Division of Pediatric Surgery, Department of Surgery, University of Florida College of Medicine, PO Box 100119, Gainesville, FL, 32610-0119, USA.

Purpose: Initial recommendations for ECMO had relative contraindications for low birth weight (BW) or low gestational age (GA) babies. However, more recent literature has demonstrated improved and acceptable outcomes of ECMO in smaller neonates. The purpose of this study was to understand both utilization and survival in patients with lower GA and BW.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!